Clinical Study Support for Biomedical Research and Surveillance in Kamphaeng Phet, Thailand
ID: PANMRA24P0000005344_NOIType: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA (B529)

Original Source

https://sam.gov/opp/f85577246dc8449bb01fc49d9e9db560/view
Timeline
    Description

    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking to negotiate a sole source contract with Kamphaeng Phet Hospital in Thailand for clinical study support related to biomedical research and surveillance. The procurement aims to provide comprehensive scientific, technical, regulatory, epidemiological, clinical, laboratory, administrative, database management, quality assurance, and logistical support to the Kamphaeng Phet - Armed Forces Research Institute of Medical Sciences Virology Research Unit (KAVRU) for various biomedical research and surveillance projects. This initiative is crucial for advancing epidemiological and clinical activities in the region, enhancing the understanding and management of health-related issues. Interested parties can contact Jaclyn Svincek at jaclyn.p.svincek.civ@health.mil or Jennifer Jackson at jennifer.c.jackson18.civ@health.mil for further details.

    Files
    No associated files provided.
    Similar Opportunities
    Intramuscular Injectable Generic Analgesic Ketamine for use in an FDA Approved Emergency Use Authorization
    Active
    Dept Of Defense
    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking manufacturers for the procurement of intramuscular injectable generic analgesic ketamine intended for use under an FDA-approved Emergency Use Authorization (EUA) for battlefield injuries. The primary objective is to identify suppliers capable of providing ready-to-inject ketamine that meets specific criteria, including being an FDA-approved generic drug available in multidose vials and ready for immediate purchase, without any combination products. This initiative is crucial for enhancing pain management strategies within the military healthcare system, particularly for acute severe pain associated with battlefield injuries. Interested parties must submit a capabilities statement by October 7, 2024, addressing various topics such as FDA status and manufacturing capacity, with all submissions becoming government property. For further inquiries, contact Timothy Kelly at timothy.j.kelly169.civ@health.mil or call 301-619-7806.
    CHEMISTRY AND IMMUNODIAGNOSTICS REAGENTS FOR Bassett Army Community Hospital
    Active
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office - Pacific, intends to modify an existing contract to procure additional Chemistry and Immunodiagnostics Reagents for the Bassett Army Community Hospital in Alaska. This modification aims to increase supply quantities under existing Contract Line Item Numbers (CLINs) for the upcoming Option Period III in Fiscal Year 2024. These reagents are critical for diagnostic testing and patient care within military medical facilities. Interested vendors can reach out to Garrett Wada at garrett.k.wada.civ@health.mil or call 808-433-9505, or contact Riley Yogi at riley.r.yogi.civ@health.mil or 808-433-9513 for further details.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    Intent to sole source Biomerieux Vitek2 Preventative maintenance and Consumables
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Biomerieux Japan Ltd. for the supply of specific VITEK 2 test cards and annual preventive maintenance services for the U.S. Naval Hospital Yokosuka and Branch Health Clinic Iwakuni in Japan. The procurement includes a delivery schedule spanning fiscal years 2025 to 2027, detailing quantities for three types of test cards essential for laboratory analyses, along with maintenance for two Vitek 2 Compact Analyzers. This contract is critical for ensuring effective healthcare delivery to U.S. Forces Japan personnel, and interested vendors may submit technical capability statements by 07:00 a.m. Pacific Time on 23 September 2024, to Raphael Badagbor at raphael.k.badagbor.civ@health.mil, as no competitive proposals will be solicited.
    Medical Reagents for USNH Okinawa
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting a sources sought announcement to identify local sources capable of providing medical laboratory reagents for the United States Naval Hospital (USNH) in Okinawa, Japan. The procurement involves the delivery of CLASS VIII medical laboratory reagents, including Ortho reagents and consumables compatible with VITROS 5600 Analyzers, along with necessary training and maintenance services for the equipment. This opportunity is critical for ensuring the availability of essential medical supplies and maintaining compliance with healthcare standards in a military setting. Interested parties must submit their qualifications and relevant information by September 30, 2024, to the primary contacts, Bradley Ah Nee and Arlene Renner, via email at bradley.ahnee@dla.mil and arlene.renner@dla.mil, respectively. The estimated contract value is under $5.4 million, covering a base period of 12 months with two optional periods.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    6550--VISN Multiplex PCR Testing Reagents/Consumables Intent to sole source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Great Lakes Acquisition Center, intends to negotiate a sole source contract with BioMerieux, Inc. for the provision of proprietary reagents and consumables necessary for PCR testing on government-owned devices across facilities in Wisconsin, Illinois, and Michigan. This procurement is essential to ensure that the VA can maintain high-quality healthcare services, as only BioMerieux is deemed capable of meeting the specialized requirements for these supplies. The contract will be established as a Blanket Purchase Agreement (BPA) under an existing contract, categorized as firm fixed price, and is being conducted in accordance with FAR 8.405-6. Interested firms must submit their qualifications and relevant customer references to the Contracting Officer, Teresa Beers, at teresa.beers@va.gov within seven calendar days from the publication date of this notice, as no competitive proposals will be solicited.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    Chemistry Molecular Cost Per Reportable Results
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking proposals for Chemistry/Immunoassay Analyzers, Reagents, and related services at the Dwight D. Eisenhower Army Medical Center located in Fort Gordon, Georgia. The procurement aims to support military healthcare operations by providing essential medical diagnostic equipment and reagents, particularly for laboratory tests focused on sexually transmitted infections, including Chlamydia trachomatis, Neisseria gonorrhea, and Human Papilloma Virus (HPV). This contract, expected to be awarded as a Firm Fixed Price agreement, includes installation, training, and ongoing maintenance, with proposals due by September 20, 2024. Interested vendors should direct inquiries to Jacquetta White at jacquetta.o.white.civ@health.mil or Sebrena L. Lane at sebrena.l.hackleylane.civ@health.mil for further details.
    6550--VISN 6 BioFire FilmArray Verification Kits.
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to negotiate a sole source contract for the procurement of BioFire FilmArray Verification Kits from Biomerieux, Inc., to meet the specialized needs of the Veterans Integrated Service Network (VISN) 6. The contract will include various diagnostic panels, with specific quantities required for each type, ensuring that the VA can provide timely and effective medical services to veterans. This procurement is critical as these specialized diagnostic supplies are only available from a single source, emphasizing the importance of maintaining compliance with federal regulations and the efficient delivery of healthcare services. Interested firms may express their capabilities to the Contract Specialist, LaToya Glover, via email by September 23, 2024, with the contract expected to be awarded effective October 1, 2024.